Identity
SNAP-8 refers to acetyl octapeptide-3; the selected study used it within a multi-ingredient microneedle patch.
Selected study only; not a complete clinical review.
Peptide library
SNAP-8
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
The paired skin trial tested a combined microneedle patch. Its effect cannot be assigned to acetyl octapeptide-3 alone or transferred to a different topical concentration, delivery system or injection.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Who was studied
24 healthy participants; 28-day paired skin study.
What the sources found
The combined patch improved measured wrinkle outcomes. Effects cannot be attributed to acetyl octapeptide-3 alone.
Regulatory scope
Current authorization for the exact product and jurisdiction was not independently checked in this snapshot. A clinical trial is not marketing authorization.
What remains unknown
Selected indexed primary-study abstract reviewed. Full methods, bias, all safety outcomes, product stability, current jurisdictional authorization and a comprehensive literature search remain outstanding. This is not a complete clinical review.
How it works
SNAP-8 refers to acetyl octapeptide-3; the selected study used it within a multi-ingredient microneedle patch.
The study-specific findings below distinguish biological activity from demonstrated treatment benefit.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Reported adverse effects
- No adverse effects were reported in this small patch study; other delivery methods were not validated.
Selected study only; not a complete clinical review.
Contraindications
- A complete contraindication and interaction review remains outstanding.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Sources used for this snapshot
Claim-by-claim evidence
Benefits
The combined patch improved measured wrinkle outcomes. Effects cannot be attributed to acetyl octapeptide-3 alone.
Selected study only; not a complete clinical review.
Adverseeffects
No adverse effects were reported in this small patch study; other delivery methods were not validated.
Selected study only; not a complete clinical review.
References
Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities. 2024.
PMID: 39082657
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.